We are live on ! Find out more
OSIR

Osiris Therapeutics, Inc. Common Stock
OSIR

Delisted

OSIR was delisted on the 16th of April, 2019.

Back to rankings

11 hedge funds and large institutions have $6.74M invested in Osiris Therapeutics, Inc. Common Stock in 2017 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 0 increasing their positions, 4 reducing their positions, and 53 closing their positions.

New
Increased
Maintained
Reduced
Closed

75% less capital invested

Capital invested by funds: $27.5M → $6.74M (-$20.7M)

83% less funds holding

Funds holding: 64 → 11 (-53)

92% less first-time investments, than exits

New positions opened: 4 | Existing positions closed: 53

99% less call options, than puts

Call options by funds: $1K | Put options by funds: $139K

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 4

Holders
11
Holders Change
-53
Holders Change %
-82.81%
% of All Funds
0.27%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.02%
New
4
Increased
–
Reduced
4
Closed
53
Calls
$1K
Puts
$139K
Net Calls
-$138K
Net Calls Change
+$688K

Top Buyers

Rank Fund Capital Flow
1
HP
HealthInvest Partners
Sweden
+$6.19M
2
Tudor Investment Corp
Tudor Investment Corp
Connecticut
+$553K
3
Simplex Trading
Simplex Trading
Illinois
+$152K
4
FPF
FNY Partners Fund
New York
+$86.9K

Top Sellers

Rank Fund Capital Flow
1
Vanguard Group
Vanguard Group
Pennsylvania
-$3.54M
2
BBA
Baker Bros. Advisors
New York
-$2.45M
3
Renaissance Technologies
Renaissance Technologies
New York
-$2.37M
4
State Street
State Street
Massachusetts
-$1.41M
5
Northern Trust
Northern Trust
Illinois
-$1.17M
Name Holding Trade Value Shares
Change 		Change in
Stake
HP
1
HealthInvest Partners
Sweden
$5.47M +$6.19M +1,140,222 New
Tudor Investment Corp
2
Tudor Investment Corp
Connecticut
$489K +$553K +101,788 New
FIM
3
Freedom Investment Management
Connecticut
$404K -$54.4K -10,015 -11%
Simplex Trading
4
Simplex Trading
Illinois
$134K +$152K +27,970 New
California Public Employees Retirement System
5
California Public Employees Retirement System
California
$78K -$4.34K -800 -5%
FPF
6
FNY Partners Fund
New York
$76K +$86.9K +16,000 New
Public Employees Retirement Association of Colorado
7
Public Employees Retirement Association of Colorado
Colorado
$58K – – –
IA
8
IFP Advisors
Florida
$21K – – –
MAM
9
Meeder Asset Management
Ohio
$2K -$10.7K -1,963 -83%
Vanguard Group
10
Vanguard Group
Pennsylvania
– -$3.54M -721,743 Closed
BBA
11
Baker Bros. Advisors
New York
– -$2.45M -499,193 Closed
Renaissance Technologies
12
Renaissance Technologies
New York
– -$2.37M -483,091 Closed
State Street
13
State Street
Massachusetts
– -$1.41M -288,550 Closed
Northern Trust
14
Northern Trust
Illinois
– -$1.17M -237,415 Closed
Millennium Management
15
Millennium Management
New York
– -$1.03M -208,979 Closed
Deutsche Bank
16
Deutsche Bank
Germany
– -$993K -202,699 Closed
Geode Capital Management
17
Geode Capital Management
Massachusetts
– -$810K -165,214 Closed
Morgan Stanley
18
Morgan Stanley
New York
– -$743K -151,345 Closed
Fidelity Investments
19
Fidelity Investments
Massachusetts
– -$739K -150,447 Closed
D.E. Shaw & Co
20
D.E. Shaw & Co
New York
– -$692K -140,978 Closed
QI
21
QS Investors
New York
– -$648K -132,027 Closed
Bank of New York Mellon
22
Bank of New York Mellon
New York
– -$419K -85,328 Closed
Charles Schwab
23
Charles Schwab
California
– -$290K -58,865 Closed
GC
24
Globeflex Capital
California
– -$281K -57,303 Closed
TCIM
25
TIAA CREF Investment Management
New York
– -$257K -52,276 Closed
1
2 3

OSIR Hedge Fund Activity: Q1 2017 in Review

11 of the 4,017 institutional investors tracked by Wall St. Rank reported a position in Osiris Therapeutics, Inc. Common Stock (OSIR) for Q1 2017, worth a combined $6.74M — down 75% from $27.5M a quarter earlier.

Sellers outnumbered buyers: 53 funds closed out of OSIR and 4 opened new positions — a net loss of 49 holders — while 4 trimmed existing stakes and 0 added.

The largest buyer was HealthInvest Partners, opening a new position worth an estimated $6.19M. The largest seller was Vanguard Group, exiting entirely with an estimated $3.54M sold.

  • 11 institutional investors held Osiris Therapeutics, Inc. Common Stock (OSIR) as of Q1 2017, down from 64 in Q4 2016.
  • Funds reported $6.74M of Osiris Therapeutics, Inc. Common Stock stock for Q1 2017, down 75% quarter-over-quarter.
  • 4 funds opened new Osiris Therapeutics, Inc. Common Stock positions in Q1 2017 and 53 closed out, a net change of -49 holders.
  • The largest Osiris Therapeutics, Inc. Common Stock buyer in Q1 2017 was HealthInvest Partners, an estimated $6.19M added.
  • The largest Osiris Therapeutics, Inc. Common Stock seller in Q1 2017 was Vanguard Group, an estimated $3.54M sold.

Based on aggregated 13F filings for Q1 2017.